Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.33 |
| ▸ | CDK4 | P11802 | 1/20 | 0.33 |
| ▸ | CCND1 | P24385 | 1/20 | 0.33 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | ALK | Q9UM73 | 3/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 4/20 | 0.31 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.31 |
| ▸ | TSPO | P30536 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18927683 | 0.94 | TSPO (0.35) | PDK2KDM4EATML3MBTL1CCNE2 | |
| SCHEMBL15791457 | 0.93 | KDM4E (0.35) | PDK2KDM4EATML3MBTL1CCNE2 | |
| SCHEMBL30025440 | 0.93 | TSPO (0.37) | PDK2KDM4EATML3MBTL1CCNE2 | |
| SCHEMBL14822288 | 0.93 | TSPO (0.37) | PDK2KDM4EATML3MBTL1CCNE2 | |
| SCHEMBL10307239 | 0.91 | KDM4E (0.40) | PDK2KDM4EATML3MBTL1CCNE2 | |
| SCHEMBL16409619 | 0.91 | KDM4E (0.40) | PDK2KDM4EATML3MBTL1PGR | |
| SCHEMBL17038465 | 0.91 | KDM4E (0.40) | PDK2KDM4EATML3MBTL1PGR | |
| SCHEMBL13566823 | 0.89 | KDM4E (0.43) | PDK2KDM4EATML3MBTL1PGR | |
| SCHEMBL30655846 | 0.89 | KDM4E (0.43) | PDK2KDM4EATML3MBTL1PGR | |
| SCHEMBL15791463 | 0.89 | CAMK2D (0.34) | PDK2KDM4EATML3MBTL1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108137499-B | Amine-based compound and organic light emitting device including the same | 株式会社LG化学 | 2021-07-09 | — | — | CN | disclosed |
| US-10862045-B2 | Amine-based compound and organic light-emitting element comprising same | LG CHEM, LTD. | 2020-12-08 | — | — | US | disclosed |
| EP-3336077-B1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEMICAL LTD (KR) | 2019-09-11 | — | — | EP | disclosed |
| EP-3336077-B1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEMICAL LTD (KR) | 2019-09-11 | — | — | EP | disclosed |
| US-20180269401-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-09-20 | — | — | US | disclosed |
| EP-3336077-A2 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG Chem, Ltd. (KR) | 2018-06-20 | — | — | EP | disclosed |
| EP-3336077-A2 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG Chem, Ltd. (KR) | 2018-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180269401-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | EML4, OR10J3, AOC2 | PDK2 3349/4885KDM4E 434/4885ATM 181/4885 |
| US-10862045-B2 | Amine-based compound and organic light-emitting element comprising same | EML4, OR10J3, AOC2 | PDK2 3349/4885KDM4E 434/4885ATM 181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.